Enyue Fang received a B.S. in medical examination from Dalian Medical University, Dalian, China, in 2016 and an M.S. in pathogenic biology from the National Institutes for Food and Drug Control (NIFDC), Beijing, China, in 2019. He received a Ph.D. in immunology from the Wuhan Institute of Biological Products. His research interest is the development of an arbovirus vaccine. In 2022, he began working at the Institute of Health Inspection and Quarantine, Chinese Academy of Inspection and Quarantine, mainly engaged in the research of detection technology of high-risk emerging pathogenic microorganisms and molecular virology research.